Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Assisted Reproduction and Genetics
Published in: Journal of Assisted Reproduction and Genetics 12/2017

01-12-2017 | Reproductive Physiology and Disease

Haptoglobin levels, but not Hp1-Hp2 polymorphism, are associated with polycystic ovary syndrome

Authors: Laura M. L. Carvalho, Cláudia N. Ferreira, Daisy K. D. de Oliveira, Kathryna F. Rodrigues, Rita C. F. Duarte, Márcia F. A. Teixeira, Luana B. Xavier, Ana Lúcia Candido, Fernando M. Reis, Ieda F. O. Silva, Fernanda M. F. Campos, Karina B. Gomes

Published in: Journal of Assisted Reproduction and Genetics | Issue 12/2017

Login to get access

Abstract

Purpose

Proteomic studies suggest an association between haptoglobin (Hp) and polycystic ovary syndrome (PCOS). Hp is a classic inflammatory marker and binds to the intravascular hemoglobin, avoiding the oxidative damages that can be caused by free hemoglobin. Inflammation and oxidative stress are important in the pathogenesis of the PCOS, one of the most frequent metabolic diseases in women.

Methods

To validate these proteomic studies, we developed a controlled cross-sectional study that aimed to evaluate the Hp levels and allelic and genotypic frequencies of Hp1-Hp2 polymorphism in Brazilian women with PCOS. We also investigated the correlation between Hp levels and several important parameters in PCOS as follows: body mass index (BMI), waist circumference (WC), fasting glucose, post-prandial glucose, homeostatic model assessment (HOMA), lipid accumulation product (LAP), C-reactive protein (CRP), and metabolization test of tetrazolium salts (MTTs—serum antioxidant capacity).

Results

Plasma Hp levels were higher in the PCOS group than in controls [8.20 (4.04) g/L; 7.98 (3.31) g/L; p = 0.018]. No significant difference was observed in the frequency of Hp1-Hp2 genotypes under additive, recessive, or dominant model of inheritance between the PCOS and the control groups. Plasma Hp levels did not differ according to the genotype. However, plasma Hp showed a negative correlation with MTT (r = − 0.383; p = 0.028), as well as a positive correlation with CRP (r = 0.361; p = 0.014) in the PCOS group.

Conclusion

Hp1-Hp2 polymorphism is not associated with PCOS but plasma Hp could be a potential biomarker for PCOS and its complications.
Literature
1.
2.
Palomba S, Falbo SSA, La Sala GB. Complications and challenges associated with polycystic ovary syndrome: current perspectives. Int J Womens Health. 2015;7:745–63.CrossRefPubMedPubMedCentral
3.
Silva FS, Sóter MO, Sales MF, Candido AL, Reis FM, Silva IF, et al. Estrogen receptor alpha gene (ESR1) Pvu II and Xba I polymorphisms are associated to metabolic and proinflammatory factors in polycystic ovary syndrome. Gene. 2015;560:44–9.CrossRefPubMed
4.
Jalilian A, Kiani F, Sayehmiri F, Sayehmiri K, Khodaee Z, Akbari M. Prevalence of polycystic ovary syndrome and its associated complications in Iranian women: a meta-analysis. Iran J Reprod Med. 2015;13(10):591–604.PubMedPubMedCentral
5.
6.
Gonzalez F, Kirwanj P, Rote NS, Minium J. Elevated circulating levels of tissue factor in polycystic ovary syndrome. Clin Appl Thromb Hemost. 2013;19(1):66–72.CrossRefPubMed
7.
Shen CC, Yang AC, Hung J, Hu LY, Tsai J. A nationwide population-based retrospective cohort study of the risk of uterine, ovarian and breast cancer in women with polycystic ovary syndrome. Oncologist. 2015;20(1):45–9.CrossRefPubMed
8.
Yu HF, Chen HS, Rao DP, Gong J. Association between polycystic ovary syndrome and the risk of pregnancy complications: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2016;95(51):48–63.
9.
Spritzer PM, Lecke SB, Satler F, Morsch DM. Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome. Reproduction. 2015;149(5):R219–27.CrossRefPubMed
10.
Sóter MO, Ferreira CN, Sales MF, Candido AL, Reis FM, Milagres KS, et al. Peripheral blood-derived cytokine gene polymorphisms and metabolic profile in women with polycystic ovary syndrome. Cytokine. 2015;76(2):227–35.CrossRefPubMed
11.
Aytan AN, Bastu E, Demiral I, Blulut H, Dogan M, Buyry F. Relationship between hyperandrogenism, obesity, inflammation and polycystic ovary syndrome. Gynecol Endocrinol. 2016;19(24):1–5.
12.
Carvalho LM, Ferreira CN, Sóter MO, Sales MF, Rodrigues KF, Martins SR, et al. Microparticles: inflammatory and haemostatic biomarkers in polycystic ovary syndrome. Mol Cell Endocrinol. 2017;443:155–62.CrossRefPubMed
13.
Mortada R, Kallail KJ, Dong F, Karakas S. HbA1c in patients with polycystic ovary syndrome: a potential marker of inflammation. J Reprod Infertil. 2015;16(4):203–6.PubMedPubMedCentral
14.
Özer A, Bakacak M, Kıran H, Ercan Ö, Köstü B, Kanat-Pektaş M, et al. Increased oxidative stress is associated with insulin resistance and infertility in polycystic ovary syndrome. Ginekol Pol. 2016;87(11):733–8.CrossRefPubMed
15.
Murri M, Luque-Ramírez M, Insenser M, Ojeda-Ojeda M, Escobar-Morreale HF. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update. 2013;19(3):268–88.CrossRefPubMed
16.
Insenser M, Martínez-García MA, Montes R, San-Millán JL, Escobar-Morreale HF. Proteomic analysis of plasma in the polycystic ovary syndrome identifies novel markers involved in iron metabolism, acute-phase response, and inflammation. J Clin Endocrinol Metab. 2010;95(8):3863–70.CrossRefPubMed
17.
Matharoo-Ball B, Hughes C, Lancashire L, Tooth D, Ball G, Creaser C, et al. Characterization of biomarkers in polycystic ovary syndrome (PCOS) using multiple distinct proteomic platforms. J Proteome Res. 2007;6:3321–8.CrossRefPubMed
18.
Ashleh R, Marsh S, Skilkrut M, Binah O, Guetta J, Lejbkowicz F, et al. Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease. Mol Med. 2003;92:1193–200.
19.
20.
Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SKA, et al. Identification of the haemoglobin scavenger receptor. Nature. 2001;409:198–201.CrossRefPubMed
21.
Langlois MR, Delanghe JR. Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem. 1996;42(10):1589–600.PubMed
22.
Shaer CA, Schoedon G, Imhof A, Kurrer MO, Schaer DJ. Constitutive endocytosis of CD163 mediates hemoglobin-heme uptake and determines the noninflammatory and protective transcriptional response of macrophages to hemoglobin. Circ Res. 2006;99(9):943–50.CrossRef
23.
Berkova N, Gilbert C, Goupil S, Yan J, Korobko V, Naccache PH. TNF-induced haptoglobin release from human neutrophils: pivotal role of the TNF p55 receptor. J Immunol. 1999;162:6226–32.PubMed
24.
Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340(6):448–54.CrossRefPubMed
25.
Nakata K, Saitoh R, Aamano J, Koshiyama A, Ichibangase T, Murao N, et al. Alteration of intracellular secretory acute phase response proteins expressed in human hepatocyte induced by exposure with interleukin-6. Cytokine. 2012;59(2):317–23.CrossRefPubMed
26.
Baumann H, Morella KK, Jahreis GP, Marinković S. Distinct regulation of the interleukin-1 and interleukin-6 response elements of the rat haptoglobin gene in rat and human hepatoma cells. Mol Cell Biol. 1990;10(11):5967–76.CrossRefPubMedPubMedCentral
27.
Friedrichs WE, Navarijo-Ashbaugh AL, Bowman BH, Yang F. Expression and inflammatory regulation of haptoglobin gene in adipocytes. Biochem Biophys Res Commun. 1995;209(1):250–6.CrossRefPubMed
28.
Kalmovarin N, Friedrichs WE, O’Brien OV, Linehan LA, Bowman BH, Yang F. Extrahepatic expression of plasma protein genes during inflammation. Inflammation. 1991;15(5):369–79.CrossRefPubMed
29.
Chiellini C, Santini F, Marsili A, Berti P, Bertacca A, Pelosini C, et al. Serum haptoglobin: a novel marker of adiposity in humans. Journal of Endocrinology and Metabolism. 2004;89(6):2678–83.CrossRef
30.
Maffei M, Barone I, Scabia G, Santini F. The multifaceted haptoglobin in the context of adipose tissue and metabolism. Endocr Rev. 2016;37(4):403–16.CrossRefPubMed
31.
32.
Szafranek T, Marsh S, Levy AP. Haptoglobin: a major susceptibility gene for diabetic vascular complications. Exp Clin Cardiol. 2002;7(2/3):113–9.PubMedPubMedCentral
33.
Gast MCW, Tinteren HV, Bontenban M, Van Hoesel RGCM, Nooji MA, Rodenhuis S, et al. Haptoglobin phenotype is not a predictor of recurrence free survival in high-risk primary breast cancer patients. BMC Cancer. 2008;8:389.CrossRefPubMedPubMedCentral
34.
Orchard TJ, Sun W, Cleary PA, Genuth SM, Lachin JM, Mcgee P, et al. Haptoglobin genotype and the rate of renal function decline in the diabetes control and complications trial/epidemiology of diabetes interventions and complications study. Diabetes. 2013;62(9):3218–23.CrossRefPubMedPubMedCentral
35.
Boettger LM, Salem RM, Handsaker RE, Peloso GM, Kathiresan S, Hirschhorn JN, et al. Recurring exon deletions in the HP (haptoglobin) gene contribute to lower blood cholesterol levels. Nat Genet. 2016;48(4):359–66.CrossRefPubMedPubMedCentral
36.
Alvarez-Blasco F, Martínez-García MA, Luque-Ramírez M, Parraza N, San Millán JL, Escobar-Morreale HF. Role of haptoglobin in polycystic ovary syndrome (PCOS), obesity and disorders of glucose tolerance in premenopausal women. PLoS One. 2009;4(5):e5606.CrossRefPubMedPubMedCentral
37.
The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41–7.CrossRef
38.
Api M, Badoglu B, Akca A, Api O, Gorden H, Cetin A. Interobserver variability of modiWedFerriman–Gallwey hirsutism score in a Turkish population. Arch Gynecol Obstet. 2009;279:473–9.CrossRefPubMed
39.
Wen-Ya M, Chung-Yi Y, Shyang-Rong S, Hong-Jen H, Chi SH, Fu-Chun C, et al. Measurement of waist circumference: midabdominal or iliac crest? Diabetes Care. 2013;36:1660–6.CrossRef
40.
Lwow F, Jedrzejuk D, Milewicz A, Szmigiero L. Lipid accumulation product (LAP) as a criterion for the identification of the healthy obesity phenotype in postmenopausal women. Exp Gerontol. 2016;82:81–7.CrossRefPubMed
41.
Godinjak A, Godinjak Z, Burekovic A, Surkovic I, Dizdarecic-Bostandizic A, Velija-asimi Z. Insulin resistance and lipid accumulation product in correlation to body mass index in women with polycystic ovary syndrome. Med Arch. 2012;66:409–11.CrossRefPubMed
42.
Tang Q, Li X, Song P, Xu L. Optimal cut-off values for the homeostasis model assessment of insulin resistance (HOMA-IR) and pre-diabetes screening: developments in research and prospects for the future. Drug Discov Ther. 2015;9:380–5.CrossRefPubMed
43.
Liu Y, Nair MG. Efficient and economical MTT assay for determining the antioxidant activity of plant natural product extracts and pure compounds. J Nat Prod. 2010;73(7):1193–5.CrossRefPubMed
44.
Duarte RCF, Golçalves LH, Campos FMF, Filho OAM, Alves MT, Fernandes AP, et al. Effect of acetylsalicylic acid on platelet activation and oxidative profile in a set of Brazilian patients with type 2 diabetes mellitus. Blood Coagul Fibrinolysis. 2014;25:01–8.CrossRef
45.
Medina LO, Veloso CA, Abreu Borges E, Isoni CA, Calsolari MR, Nogueira-Machado JÁ. Determination of the antioxidant status of plasma from type 2 diabetic patients. Diabetes Res Clin Pract. 2007;77:193–7.CrossRefPubMed
46.
Koch W, Latz W, Eichinger M, Roguin A, Levy AP, Schömig A, et al. Genotyping of the common haptoglobin Hp1/2 polymorphism based on PCR. Clin Chem. 2002;48(9):1377–82.PubMed
47.
Taylor R. Interpretation of the correlation coefficient: a basic review. J Diagn Med Sonography. 1990;6:35–9.CrossRef
48.
49.
50.
Bachelot A. Polycystic ovarian syndrome: clinical and biological diagnosis. Ann Biol Clin. 2016;74(6):661–7.
51.
Zheng SH, Li XL. Visceral adiposity index as a predictor of clinical severity and therapeutic outcome of PCOS. Gynecol Endocrinol. 2016;32(3):177–83.CrossRefPubMed
52.
53.
Kushner MAI. It’s time to redefine inflammation. J Clin Endocrinol Metab. 2010;95(8):3863–70.CrossRef
54.
Haoula Z, Shaw B, Daykin C, Hodgman C, Layfield R, Atiomo W. Validation of proteomic biomarkers previously found to be differentially expressed in women with polycystic ovary syndrome: a cross-sectional study. Gynecol Endocrinol. 2014;30(3):213–6.CrossRefPubMed
55.
Chiellini C, Bertacca A, Novelli SE, et al. Obesity modulates the expression of haptoglobin in the white adipose tissue via TNF-α. J Cell Physiol. 2002;190(2):251–8.CrossRefPubMed
56.
De Pergola G, Di Roma P, Paoli G, Guida P, Pannacciulli N, et al. Haptoglobin serum levels are independently associated with insulinemia in overweight and obese women. J Endocrinol Investig. 2007;30:399–403.CrossRef
Metadata
Title
Haptoglobin levels, but not Hp1-Hp2 polymorphism, are associated with polycystic ovary syndrome
Authors
Laura M. L. Carvalho
Cláudia N. Ferreira
Daisy K. D. de Oliveira
Kathryna F. Rodrigues
Rita C. F. Duarte
Márcia F. A. Teixeira
Luana B. Xavier
Ana Lúcia Candido
Fernando M. Reis
Ieda F. O. Silva
Fernanda M. F. Campos
Karina B. Gomes
Publication date
01-12-2017
Publisher
Springer US
Published in
Journal of Assisted Reproduction and Genetics / Issue 12/2017
Print ISSN: 1058-0468
Electronic ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-017-1030-3

Other articles of this Issue 12/2017

Journal of Assisted Reproduction and Genetics 12/2017 Go to the issue

Assisted Reproduction Technologies

Retrospective analysis of treatments with recombinant FSH and recombinant LH versus human menopausal gonadotropin in women with reduced ovarian reserve

Gamete Biology

CoQ10 increases mitochondrial mass and polarization, ATP and Oct4 potency levels, and bovine oocyte MII during IVM while decreasing AMPK activity and oocyte death

Genetics

The role of gene polymorphisms and AMH level in prediction of poor ovarian response in Egyptian women undergoing IVF procedure

Embryo Biology

Mitochondrial DNA content is associated with ploidy status, maternal age, and oocyte maturation methods in mouse blastocysts

Commentary

Genetic affinity and the right to ‘three-parent IVF’

Technological Innovations

Positive rheotaxis extended drop: a one-step procedure to select and recover sperm with mature chromatin for intracytoplasmic sperm injection